Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease renal cell carcinoma
Comorbidity C0020538|hypertension
Sentences 11
PubMedID- 24595903 1guidance on monitoring and managing hypertension in patients with renal cell carcinoma treated with axitinib.
PubMedID- 25393631 Relative to other racial/ethnic groups, blacks had the highest proportion of renal cell carcinoma incidence attributable to hypertension and chronic kidney disease (combined, par = 37%; hypertension only, par = 27%; chronic kidney disease, par = 10%).
PubMedID- 24978482 Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid.
PubMedID- 23966283 Objectives: this study evaluated whether particular diabetes mellitus (dm), hyperlipidemia, or hypertension pharmacotherapy was associated with improved renal cell carcinoma (rcc) outcomes in diabetics with emergent rcc.
PubMedID- 22876146 hypertension management in patients with renal cell cancer treated with anti-angiogenic agents.
PubMedID- 21719394 The patient had a history of arterial hypertension, nephrectomy because of a hypernephroma (pt1a) one year ago and a solitary concrement of the gall bladder (figure 1).
PubMedID- 26081424 Association of hypertension and obesity with renal cell carcinoma risk: a report from the shanghai men's and women's health studies.
PubMedID- 22948895 Next, the association between hypertension and survival in patients with metastatic renal cell cancer (mrcc) was studied.
PubMedID- 23665301 Conclusions: we identified a significant association of renal cell carcinoma with obesity, smoking, hypertension, renal disease and viral hepatitis.
PubMedID- 21602426 When combined with obesity and hypertension, the elevated risk of renal cell cancer is high.
PubMedID- 24621095 A significantly higher incidence of hypertension was noted in patients with renal cell carcinoma (rcc) compared with those with non-rcc malignancies (all-grade: 24.9% [95% ci, 19.7%-30.1%] vs 15.7%[95% ci, 12.1%-19.3%]; p<.05; high-grade:8.6% [95% ci, 6.0%-11.2%] vs 1.8% [95% ci, 0.9%-2.6%]; p<.05).

Page: 1